Aerie Pharmaceuticals Current Ratio 2012-2020 | AERI

Aerie Pharmaceuticals current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aerie Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.34B $0.08B 4.28
2019-12-31 $0.38B $0.08B 4.50
2019-09-30 $0.40B $0.07B 5.43
2019-06-30 $0.15B $0.06B 2.52
2019-03-31 $0.18B $0.05B 3.47
2018-12-31 $0.22B $0.05B 4.34
2018-09-30 $0.25B $0.04B 7.05
2018-06-30 $0.30B $0.03B 10.27
2018-03-31 $0.34B $0.03B 13.57
2017-12-31 $0.25B $0.03B 10.09
2017-09-30 $0.28B $0.02B 15.24
2017-06-30 $0.31B $0.01B 22.45
2017-03-31 $0.21B $0.01B 15.50
2016-12-31 $0.24B $0.02B 12.27
2016-09-30 $0.26B $0.01B 18.20
2016-06-30 $0.11B $0.01B 7.65
2016-03-31 $0.12B $0.02B 7.52
2015-12-31 $0.14B $0.02B 8.09
2015-09-30 $0.16B $0.02B 8.46
2015-06-30 $0.16B $0.02B 8.76
2015-03-31 $0.17B $0.02B 7.64
2014-12-31 $0.14B $0.01B 15.87
2014-09-30 $0.17B $0.01B 24.54
2014-06-30 $0.06B $0.01B 11.82
2014-03-31 $0.07B $0.00B 17.83
2013-12-31 $0.07B $0.00B 20.18
2013-09-30 $0.01B $0.02B 0.39
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2011-12-31 $0.02B $0.00B 5.63
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.652B $0.070B
Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are under developmental stages. Aerie Pharmaceuticals, Inc. is headquartered in Bedminster, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.202B 37.57
Takeda Pharmaceutical (TAK) Japan $61.479B 10.77
Astellas Pharma (ALPMY) Japan $33.697B 0.00
Eisai (ESALY) Japan $23.132B 0.00
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $13.984B 0.00
Grifols, S.A (GRFS) Spain $13.015B 16.18
Catalent (CTLT) United States $12.040B 46.54
Neurocrine Biosciences (NBIX) United States $11.586B 53.54
Ionis Pharmaceuticals (IONS) United States $7.831B 41.64
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Orion OYJ (ORINY) Finland $7.628B 34.18
IPSEN SA ADR (IPSEY) France $6.677B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.602B 10.57
United Therapeutics (UTHR) United States $5.191B 9.84
Evotec AG (EVTCY) Germany $4.079B 0.00
Hypermarcas (HYPMY) Brazil $3.882B 0.00
Nektar Therapeutics (NKTR) United States $3.862B 0.00
ChemoCentryx (CCXI) United States $3.859B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.281B 358.22
PTC Therapeutics (PTCT) United States $3.188B 0.00
FibroGen (FGEN) United States $2.980B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.607B 10.71
Cronos Group (CRON) Canada $2.278B 65.30
Sage Therapeutics (SAGE) United States $1.855B 0.00
Pacira BioSciences (PCRX) United States $1.851B 37.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.782B 0.00
USANA Health Sciences (USNA) United States $1.780B 18.26
Corcept Therapeutics (CORT) United States $1.735B 17.20
Xencor (XNCR) United States $1.724B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Zogenix (ZGNX) United States $1.612B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.593B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.551B 11.87
Akebia Therapeutics (AKBA) United States $1.516B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.458B 15.71
Portola Pharmaceuticals (PTLA) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.352B 0.00
Translate Bio (TBIO) United States $1.303B 0.00
Tilray (TLRY) Canada $1.228B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.170B 0.00
Indivior (INVVY) United States $1.052B 13.06
Enanta Pharmaceuticals (ENTA) United States $1.030B 45.97
Endo (ENDP) Ireland $0.887B 1.37
ImmunoGen (IMGN) United States $0.816B 0.00
Collegium Pharmaceutical (COLL) United States $0.757B 0.00
Molecular Templates (MTEM) United States $0.709B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.694B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Radius Health (RDUS) United States $0.587B 0.00
Trillium Therapeutics (TRIL) Canada $0.566B 0.00
Harpoon Therapeutics (HARP) United States $0.544B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.541B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.537B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.485B 0.00
DURECT (DRRX) United States $0.459B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.456B 17.82
Catalyst Pharmaceuticals (CPRX) United States $0.446B 10.77
Flexion Therapeutics (FLXN) United States $0.441B 0.00
Organogenesis Holdings (ORGO) United States $0.438B 0.00
Calithera Biosciences (CALA) United States $0.410B 0.00
MEI Pharma (MEIP) United States $0.387B 0.00
Ocular Therapeutix (OCUL) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.315B 0.00
Lannett Co Inc (LCI) United States $0.309B 6.77
TherapeuticsMD (TXMD) United States $0.307B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Redhill Biopharma (RDHL) Israel $0.251B 0.00
KalVista Pharmaceuticals (KALV) United States $0.201B 0.00
VAXART, INC (VXRT) United States $0.199B 0.00
PROFOUND MEDICL (PROF) Canada $0.198B 0.00
OptiNose (OPTN) United States $0.198B 0.00
Xeris Pharmaceuticals (XERS) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 24.87
Jounce Therapeutics (JNCE) United States $0.184B 4.38
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
IMV INC (IMV) Canada $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.164B 0.00
Altimmune (ALT) United States $0.144B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.130B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
CTI BioPharma (CTIC) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.069B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
Opiant Pharmaceuticals (OPNT) United States $0.047B 101.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
PolarityTE (PTE) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.037B 7.02
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00